[Federal Register Volume 87, Number 245 (Thursday, December 22, 2022)]
[Notices]
[Pages 78638-78639]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27836]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-37-2022]


Foreign-Trade Zone (FTZ) 35--Philadelphia, Pennsylvania, 
Authorization of Production Activity, Piramal Pharma Solutions 
(Pharmaceutical Products), Sellersville, Pennsylvania

    On August 19, 2022, Piramal Pharma Solutions submitted a 
notification of proposed production activity to the FTZ

[[Page 78639]]

Board for its facility within FTZ 35, in Sellersville, Pennsylvania.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (87 FR 52505-52506, August 26, 2022). 
On December 19, 2022, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including Section 400.14.

    Dated: December 19, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-27836 Filed 12-21-22; 8:45 am]
BILLING CODE 3510-DS-P